Cholesterol Disorders

Statin Treatment and Duration Associated with Reduced Risk of Hemorrhagic Stroke
December 09, 2022

Similar reduction in risk was reported for both lobar and nonlobar intracranial hemorrhage with longer statin treatment associated with greater protection, according to Danish investigators.

Bempedoic Acid Meets Primary Endpoint in Key Cardiovascular Outcomes Trial: CLEAR
December 08, 2022

Approved in 2020 as Nexletol, bempedoic acid as the first ATP citrate lyase inhibitor and oral non-statin therapy to meet the MACE-4 primary endpoint.

Statin Prescribing in Primary Care Boosted with EHR Prompts Plus Patient Alerts
December 05, 2022

An EHR prompt to a physician alone or in combination with a previsit patient prompt both increased statin prescribing in primary care but a patient prompt alone did not.

Daily Dose: ASCVD Risk Reduced by 10% with Diet
December 02, 2022

Your daily dose of clinical news you may have missed.

ASCVD Risk Reduced by 10% with Diet, Greater Drops Seen in Women, Black Adults
December 01, 2022

The therapeutic impact of the dietary lifestyle intervention and the differential effects could have major implications for clinical care and policy, say study authors.

Daily Dose: HDL Cholesterol May No Longer be So "Good"
November 23, 2022

Your daily dose of clinical news you may have missed.

HDL Cholesterol May Not Universally Predict Risk for CHD, May No Longer be So "Good"
November 22, 2022

The analysis of a large biracial cohort found low levels of HDL-C linked to increased CHD risk in White but not Black adults and high HDL-C was not protective in either group.

Daily Dose: Remote Hypertension and Lipid Program
November 14, 2022

Your daily dose of clinical news you may have missed.

Fully Remote Intervention for Hypertension, Lipids Proves Feasible, Successful in Large, Diverse Health Care Network
November 11, 2022

The Mass General Brigham clinical intervention and study included 10 000 participants and resulted in significant reductions in SBP/DBP and LDL-C.

Early-onset Type 2 Diabetes Linked to Significantly Increased Risk for CVD in Later Life: Study
September 13, 2022

A 5-fold greater risk for all-cause or CVD-related death in persons diagnosed with T2D before age 40 years should be a call to action for enhanced screening, study authors state.